


Platform vendor that generated the purchase (apple, google, …) Should match your account’s Secret Key (found in your Dashboard Settings), to ensure that Fovea is calling your endpoint and not someone else.Īn object whose keys are product identifiers and values are Purchase objects. Only available it type is purchases.updated. The Purchases Collection object, see below. See the applicationUsername documentation. purchases.updated – A user’s purchases collection have been refreshed.The body will be a JSON object containing the webhook type and the associateed data. Webhook Requestįovea will call your webhook URL request using the POST method. The format of the request sent to your server is described below. The webhook might be extended with new message types.

#Swift publisher free trial period Activator
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. Almekhlafi MA, Eesa M, Menon BK, Demchuk AM, Goyal M. Stent-retriever thrombectomy after intravenous t-PA vs. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Strategies for reducing the door-to-balloon time in acute myocardial infarction. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Endovascular treatment for acute ischemic stroke. Ciccone A, Valvassori L SYNTHESIS Expansion Investigators. Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR Thrombectomy for Acute Revascularization study. Menon BK, Almekhlafi MA, Pereira VM, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Address correspondence to M.G., Seaman Family MR Research Centre, Foothills Medical Centre, 1403-29th St NW, Calgary, AB, Canada T2N 2T9 (e-mail: ).From the Departments of Radiology and Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada (M.G., B.K.M.) Departments of Neurology and Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa (A.P.J., T.J.) Department of Neuroradiology, Hôpital Gui-de-Chauliac, Montpellier, France (A.B.) Department of Neurology, University Hospital of University Duisburg-Essen, Essen, Germany (H.D.) Division of Neuroradiology and Division of Neurosurgery, Department of Medical Imaging and Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada (V.M.P.) Department of Neurosurgery, State University of New York at Buffalo, Buffalo, NY (E.L.) Department of Radiology, Erlanger Hospital at the University of Tennessee, Chattanooga, Tenn (B.B.) and Division of Interventional Neuroradiology (R.J.) and Department of Neurology and Comprehensive Stroke Center (J.L.S.), David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, Calif.
